February 2015 - Cancer Currents Blog
-
Genetic Studies Yield Clues to Treatment-Related Side Effects in Children with Cancer
Researchers have identified genetic variations in children with brain cancer that increased their risk of rapid hearing loss after treatment.
-
New from NCI: Resources, Tools, and News
NCI is constantly publishing new information on its websites, so periodically we provide updates on new content of interest to the cancer community.
-
"Flipping the Switch": An Interview with Dr. Mark Gilbert, Chief of NIH’s Neuro-Oncology Branch
NCI's Dr. Mark Gilbert discusses new developments in neuro-oncology and the priorities of the Neuro-Oncology Branch.
-
Exposure to Secondhand Smoke Plummets, but Disparities Persist
Second-hand smoke exposure has fallen by 50 percent since 1999, a new study finds, but millions are still routinely exposed to secondhand smoke.
-
FDA Grants Palbociclib Accelerated Approval for Advanced Breast Cancer
Palbociclib (Ibrance) is approved to be used in combination with letrozole (Femara) to treat postmenopausal women with metastatic breast cancer.
-
Medicare to Cover Annual Lung Cancer Screening for Some Beneficiaries
For the first time, Medicare will cover the costs of lung cancer screening for some beneficiaries, the Centers for Medicare and Medicaid Services (CMS) announced on February 5.
-
Genome Study Yields Clues to Head and Neck Cancers
Researchers have surveyed the genetic changes in nearly 300 head and neck cancers, revealing some previously unknown alterations that may play a role in the disease, including in patients whose cancer is associated with the human papillomavirus (HPV).